07:00 , Jul 11, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine/metabolic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Diabetes Peptidylprolyl cis-trans isomerase NIMA-interacting 4 (PIN4; PAR14) Cell culture and mouse studies suggest increasing PIN4 expression could help treat diabetes. In a human...